Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Topical doxycycline foam 4% for prophylactic management of epidermal growth factor receptor inhibitor skin toxicity: an exploratory phase 2, randomized, double-blind clinical study.
Shacham Shmueli E, Geva R, Yarom N, Hubert A, Keynan R, Kedem TH, Eini M, Tamarkin D, Shirvan M. Shacham Shmueli E, et al. Among authors: tamarkin d. Support Care Cancer. 2019 Aug;27(8):3027-3033. doi: 10.1007/s00520-018-4600-8. Epub 2019 Jan 4. Support Care Cancer. 2019. PMID: 30607677 Clinical Trial.
Emollient foam in topical drug delivery.
Tamarkin D, Friedman D, Shemer A. Tamarkin D, et al. Expert Opin Drug Deliv. 2006 Nov;3(6):799-807. doi: 10.1517/17425247.3.6.799. Expert Opin Drug Deliv. 2006. PMID: 17076601
11 results